Following positive research data , retatrutide, a novel peptide option for treating adult-onset metabolic disorder, has received regulatory approval from the Healthcare and Healthcare Agency ( MHRA https://geraldxlni890664.alltdesign.com/retatrutide-compound-peptide-british-approval-and-access-59688523